Default company panoramic image
D38e353e 80b5 47ee a32d 667c3f3c3fdb

Recombinetics, Inc. (RCI)

Transforming Public Health by Engineering Animals for Biomedicine & Food Production .

  • Stage Product In Development
  • Industry Biotechnology
  • Location St Paul, MN, USA
  • Currency USD
  • Founded August 2008
  • Employees 9
  • Website recombinetics.com

Company Summary

Recombinetics has developed and acquired a portfolio of proprietary genome engineering technologies it uses to make precise modifications to the genomes of several livestock species. The results are animals with enhanced value for biomedicine and agricultural markets. First products are pigs that exhibit human heart disease. Customers are academic scientists, pharmaceutical and medical device companies, and CROs that want a consistent model.

Team

  • Default avatar
    Scott Fahrenkrug
    CEO & Chairman

  • Default avatar
    Mark Walton
    CMO (Chief Marketing Officer)

  • Default avatar
    Perry Hackett
    CSO (Chief Scientific Officer)

  • Default avatar
    Justin Zenanko
    CFO

  • Default avatar
    Cliff Steer
    CMO (Chief Medical Officer)

Advisors

  • Default avatar
    General: Cameron Law Office, Business: Larkin & Hoffman, IP: Dardi & Herbert, LLP
    Lawyer
    Unconfirmed
    Default avatar
    Audits: Olsen Thielen, Taxation & General: Deloitte Touche
    Accountant
    Unconfirmed

Previous Investors

  • Default avatar
    Founders, Friends and Family
    Unconfirmed